This product is not clubbable with other items in cart. Please remove this or other items to proceed further.
No Items In Cart
There is an increasing trend in the pharmaceutical industry for ready-to-use components for a variety of reasons.
As a result, customers are looking to their manufacturing suppliers to help them address the following challenges:
Daikyo RSV (ready-to-sterilize validated) and RUV (ready-to-use validated) components allow customers more time to focus on their own drug manufacturing needs. Daikyo RUV components are delivered to customers ready-to-use on their filling lines. The components are manufactured using high-quality elastomer formulations, pharmaceutically washed, 100% camera-inspected and steam sterilized. The Daikyo RUV process is fully validated, filed in Drug Master Files in the U.S. and Canada, and utilizes an overkill method based on ISO 17665-1 to provide a sterility assurance level (SAL) of 10-6 or better.
Each batch of product is provided with specification for bioburden, particulate and endotoxin. Daikyo RUV components adhere to rigorous quality standards and provide customers regulatory acceptance and flexibility.
Additionally, the RUV offering is available in small quantities to meet your clinical trial and scale-up needs and enable manufacturing flexibility.
To learn more about the latest component offering from West, click here to learn more about Daikyo RUV components or contact your Account Manager or Technical Account Specialist for more details.
Take an in-depth look at the science behind containment & delivery of injectable medicines in the West Knowledge Center.